These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23364509)

  • 1. Predicting metabolic clearance for drugs that are actively transported into hepatocytes: incubational binding as a consequence of in vitro hepatocyte concentration is a key factor.
    Nordell P; Svanberg P; Bird J; Grime K
    Drug Metab Dispos; 2013 Apr; 41(4):836-43. PubMed ID: 23364509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic Clearance Assay Incubational Binding: A Method Comparison.
    Chen S; Prieto Garcia L; Bergström F; Nordell P; Grime K
    Drug Metab Dispos; 2017 Apr; 45(4):342-345. PubMed ID: 28122786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
    Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional consequences of active hepatic uptake on cytochrome P450 inhibition in rat and human hepatocytes.
    Grime K; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2008 Aug; 36(8):1670-8. PubMed ID: 18474678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte composition-based model as a mechanistic tool for predicting the cell suspension: aqueous phase partition coefficient of drugs in in vitro metabolic studies.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Aug; 102(8):2806-18. PubMed ID: 23670739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo.
    Soars MG; Grime K; Sproston JL; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2007 Jun; 35(6):859-65. PubMed ID: 17344337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes.
    Sohlenius-Sternbeck AK; Jones C; Ferguson D; Middleton BJ; Projean D; Floby E; Bylund J; Afzelius L
    Xenobiotica; 2012 Sep; 42(9):841-53. PubMed ID: 22509824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
    Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
    Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic intrinsic clearance in freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykiss): determination of trout hepatocellularity, optimization of cell concentrations and comparison of serum and serum-free incubations.
    Han X; Mingoia RT; Nabb DL; Yang CH; Snajdr SI; Hoke RA
    Aquat Toxicol; 2008 Aug; 89(1):11-7. PubMed ID: 18599132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
    Francis LJ; Houston JB; Hallifax D
    Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
    Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
    Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
    Shibata Y; Takahashi H; Ishii Y
    Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds.
    Sohlenius-Sternbeck AK; Afzelius L; Prusis P; Neelissen J; Hoogstraate J; Johansson J; Floby E; Bengtsson A; Gissberg O; Sternbeck J; Petersson C
    Xenobiotica; 2010 Sep; 40(9):637-49. PubMed ID: 20624033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes.
    Jigorel E; Houston JB
    Drug Metab Dispos; 2012 Aug; 40(8):1596-602. PubMed ID: 22593038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.